{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T01:34:49Z","timestamp":1792460089442,"version":"4.5.0"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.ejpb.2018.04.023","type":"journal-article","created":{"date-parts":[[2018,4,22]],"date-time":"2018-04-22T16:59:07Z","timestamp":1524416347000},"page":"156-169","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":167,"special_numbering":"C","title":["Self-assembled amphiphilic zein-lactoferrin micelles for tumor targeted co-delivery of rapamycin and wogonin to breast cancer"],"prefix":"10.1016","volume":"128","author":[{"given":"Sally A.","family":"Sabra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed O.","family":"Elzoghby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salah A.","family":"Sheweita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Medhat","family":"Haroun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maged W.","family":"Helmy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maha A.","family":"Eldemellawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Goodale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison L.","family":"Allan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sohrab","family":"Rohani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ejpb.2018.04.023_b0005","first-page":"87","article-title":"Global cancer statistics, 2012","volume":"65","author":"Torre","year":"2015","journal-title":"CA: A Cancer J. Clin."},{"issue":"13","key":"10.1016\/j.ejpb.2018.04.023_b0010","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1200\/JCO.2008.20.0766","article-title":"Targeting the mTOR signaling network for cancer therapy","volume":"27","author":"Meric-Bernstam","year":"2009","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.ejpb.2018.04.023_b0015","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.cmet.2014.01.001","article-title":"Rapamycin: one drug, many effects","volume":"19","author":"Li","year":"2014","journal-title":"Cell Metab."},{"issue":"1\u20134","key":"10.1016\/j.ejpb.2018.04.023_b0020","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s12154-008-0003-5","article-title":"Rapamycin and mTOR kinase inhibitors","volume":"1","author":"Ballou","year":"2008","journal-title":"J. Chem. Biol."},{"issue":"1","key":"10.1016\/j.ejpb.2018.04.023_b0025","doi-asserted-by":"crossref","DOI":"10.1186\/1749-8090-7-17","article-title":"Retraction: Rapamycin-loaded nanoparticles for inhibition of neointimal hyperplasia in experimental vein grafts","volume":"7","author":"Zou","year":"2012","journal-title":"J. Cardiothor. Surg."},{"issue":"1","key":"10.1016\/j.ejpb.2018.04.023_b0030","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00280-007-0458-z","article-title":"Pharmacometrics and delivery of novel nanoformulated PEG-b-poly(\u03b5-caprolactone) micelles of rapamycin","volume":"61","author":"Y\u00e1\u00f1ez","year":"2008","journal-title":"Cancer Chemot. Pharmacol."},{"issue":"8","key":"10.1016\/j.ejpb.2018.04.023_b0035","doi-asserted-by":"crossref","first-page":"986","DOI":"10.3109\/03639045.2011.553618","article-title":"The influence of co-solvents on the stability and bioavailability of rapamycin formulated in self-microemulsifying drug delivery systems","volume":"37","author":"Sun","year":"2011","journal-title":"Drug Dev. Ind. Pharmacy"},{"issue":"1","key":"10.1016\/j.ejpb.2018.04.023_b0040","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/ndt\/gfh639","article-title":"Nephrotoxicity of rapamycin: an emerging problem in clinical medicine","volume":"20","author":"Marti","year":"2005","journal-title":"Nephrol. Dial. Transplant."},{"issue":"8","key":"10.1016\/j.ejpb.2018.04.023_b0045","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.2337\/db13-0106","article-title":"Evidence for rapamycin toxicity in pancreatic \u03b2-cells and a review of the underlying molecular mechanisms","volume":"62","author":"Barlow","year":"2013","journal-title":"Diabetes"},{"issue":"22","key":"10.1016\/j.ejpb.2018.04.023_b0050","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.2217\/nnm-2016-0236","article-title":"Layer-by-layer-coated lyotropic liquid crystalline nanoparticles for active tumor targeting of rapamycin","volume":"11","author":"Freag","year":"2016","journal-title":"Nanomedicine"},{"issue":"6","key":"10.1016\/j.ejpb.2018.04.023_b0055","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/ncponc1112","article-title":"Rapamycin treatment for a child with germline PTEN mutation","volume":"5","author":"Marsh","year":"2008","journal-title":"Nat. Clin. Pract. Oncol."},{"issue":"6","key":"10.1016\/j.ejpb.2018.04.023_b0060","first-page":"401","article-title":"H.-W. ZHANG, and C. Bao-An, Main signal pathways underlying the molecular mechanisms of the antitumor effects of wogonin","volume":"10","author":"Miao-Xin","year":"2012","journal-title":"Chin. J. Nat. Med."},{"issue":"5","key":"10.1016\/j.ejpb.2018.04.023_b0065","doi-asserted-by":"crossref","first-page":"5538","DOI":"10.3390\/molecules19055538","article-title":"Pharmacokinetics, tissue distribution, excretion and plasma protein binding studies of wogonin in rats","volume":"19","author":"Talbi","year":"2014","journal-title":"Molecules"},{"issue":"1\u20132","key":"10.1016\/j.ejpb.2018.04.023_b0070","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ijpharm.2017.06.077","article-title":"Superiority of aromatase inhibitor and cyclooxygenase-2 inhibitor combined delivery: Hyaluronate-targeted versus PEGylated protamine nanocapsules for breast cancer therapy","volume":"529","author":"Elzoghby","year":"2017","journal-title":"Int. J. Pharm."},{"issue":"12","key":"10.1016\/j.ejpb.2018.04.023_b0075","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/nnano.2007.387","article-title":"Nanocarriers as an emerging platform for cancer therapy","volume":"2","author":"Peer","year":"2007","journal-title":"Nat. Nanotechnol."},{"issue":"7","key":"10.1016\/j.ejpb.2018.04.023_b0080","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1038\/mt.2014.27","article-title":"Colocalized delivery of rapamycin and paclitaxel to tumors enhances synergistic targeting of the PI3K\/Akt\/mTOR pathway","volume":"22","author":"Blanco","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ejpb.2018.04.023_b0085","article-title":"Self-assembled nanocarriers based on amphiphilic natural polymers for anti-cancer drug delivery applications","author":"Sabra","year":"2017","journal-title":"Curr. Pharm. Des."},{"issue":"1","key":"10.1016\/j.ejpb.2018.04.023_b0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11095-006-9132-0","article-title":"Micellar nanocarriers: pharmaceutical perspectives","volume":"24","author":"Torchilin","year":"2007","journal-title":"Pharm. Res."},{"issue":"1","key":"10.1016\/j.ejpb.2018.04.023_b0095","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jconrel.2005.09.034","article-title":"Block copolymer micelles: preparation, characterization and application in drug delivery","volume":"109","author":"Gaucher","year":"2005","journal-title":"J. Control. Release"},{"issue":"22","key":"10.1016\/j.ejpb.2018.04.023_b0100","doi-asserted-by":"crossref","first-page":"3305","DOI":"10.2174\/1381612822666160204120829","article-title":"Natural polymeric nanoparticles for brain-targeting: implications on drug and gene delivery","volume":"22","author":"Elzoghby","year":"2016","journal-title":"Curr. Pharm. Des."},{"issue":"3","key":"10.1016\/j.ejpb.2018.04.023_b0105","doi-asserted-by":"crossref","first-page":"110","DOI":"10.4172\/2157-7439.1000110","article-title":"Biopolymeric nanoparticles for oral protein delivery: design and in vitro evaluation","volume":"2","author":"Elgindy","year":"2011","journal-title":"J. Nanomed. Nanotechnol."},{"key":"10.1016\/j.ejpb.2018.04.023_b0110","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/bs.apcsb.2014.12.002","article-title":"Chapter six-implications of protein-and peptide-based nanoparticles as potential vehicles for anticancer drugs","volume":"98","author":"Elzoghby","year":"2015","journal-title":"Adv. Protein Chem. Struct. Biol."},{"issue":"9","key":"10.1016\/j.ejpb.2018.04.023_b0115","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1021\/mp2006455","article-title":"Synthesis of novel biodegradable methoxy poly(ethylene glycol)\u2013zein micelles for effective delivery of curcumin","volume":"9","author":"Podaralla","year":"2012","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2018.04.023_b0120","article-title":"Zein-based nanocarriers as potential natural alternatives for drug and gene delivery: Focus on cancer therapy","author":"Elzoghby","year":"2017","journal-title":"Curr. Pharm. Des."},{"issue":"7","key":"10.1016\/j.ejpb.2018.04.023_b0125","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1007\/s11095-013-1067-7","article-title":"The immunogenicity of polyethylene glycol: facts and fiction","volume":"30","author":"Schellekens","year":"2013","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2018.04.023_b0130","unstructured":"R.M. Samarasinghe, et al., Nano-lactoferrin in diagnostic, imaging and targeted delivery for cancer and infectious diseases, J. Cancer Sci. Therapy, 2012. 2012."},{"issue":"8","key":"10.1016\/j.ejpb.2018.04.023_b0135","doi-asserted-by":"crossref","first-page":"644","DOI":"10.7150\/jca.7093","article-title":"A target-specific oral formulation of doxorubicin-protein nanoparticles: efficacy and safety in hepatocellular cancer","volume":"4","author":"Golla","year":"2013","journal-title":"J. Cancer"},{"issue":"3","key":"10.1016\/j.ejpb.2018.04.023_b0140","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2217\/nnm.15.199","article-title":"Multimodal iron oxide (Fe3O4)-saturated lactoferrin nanocapsules as nanotheranostics for real-time imaging and breast cancer therapy of claudin-low, triple-negative (ER-\/PR-\/HER2-)","volume":"11","author":"Kanwar","year":"2016","journal-title":"Nanomedicine"},{"issue":"1","key":"10.1016\/j.ejpb.2018.04.023_b0145","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1006\/abio.1994.1144","article-title":"A method for the high efficiency of water-soluble carbodiimide-mediated amidation","volume":"218","author":"Sehgal","year":"1994","journal-title":"Anal. Biochem."},{"issue":"1","key":"10.1016\/j.ejpb.2018.04.023_b0150","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ijpharm.2011.03.047","article-title":"Biopolymeric microparticles combined with lyophilized monophase dispersions for controlled flutamide release","volume":"411","author":"Elgindy","year":"2011","journal-title":"Int. J. Pharm."},{"issue":"5","key":"10.1016\/j.ejpb.2018.04.023_b0155","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1021\/ma00005a010","article-title":"Poly(styrene-ethylene oxide) block copolymer micelle formation in water: a fluorescence probe study","volume":"24","author":"Wilhelm","year":"1991","journal-title":"Macromolecules"},{"issue":"1","key":"10.1016\/j.ejpb.2018.04.023_b0160","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ijpharm.2015.06.015","article-title":"Swellable floating tablet based on spray-dried casein nanoparticles: near-infrared spectral characterization and floating matrix evaluation","volume":"491","author":"Elzoghby","year":"2015","journal-title":"Int. J. Pharm."},{"issue":"10","key":"10.1016\/j.ejpb.2018.04.023_b0165","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1007\/s11095-013-1091-7","article-title":"Micellar delivery of flutamide via milk protein nanovehicles enhances its anti-tumor efficacy in androgen-dependent prostate cancer rat model","volume":"30","author":"Elzoghby","year":"2013","journal-title":"Pharm. Res."},{"issue":"3","key":"10.1016\/j.ejpb.2018.04.023_b0170","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.ejpb.2013.07.003","article-title":"Ionically-crosslinked milk protein nanoparticles as flutamide carriers for effective anticancer activity in prostate cancer-bearing rats","volume":"85","author":"Elzoghby","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"40","key":"10.1016\/j.ejpb.2018.04.023_b0175","doi-asserted-by":"crossref","first-page":"16890","DOI":"10.1039\/C5NR02831K","article-title":"Lactoferrin conjugated iron oxide nanoparticles for targeting brain glioma cells in magnetic particle imaging","volume":"7","author":"Tomitaka","year":"2015","journal-title":"Nanoscale"},{"key":"10.1016\/j.ejpb.2018.04.023_b0180","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.ejpb.2017.05.003","article-title":"Curcumin loading potentiates the chemotherapeutic efficacy of selenium nanoparticles in HCT116 cells and Ehrlich\u2019s ascites carcinoma bearing mice","volume":"117","author":"Kumari","year":"2017","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"15","key":"10.1016\/j.ejpb.2018.04.023_b0185","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1038\/sj.gt.3302281","article-title":"Potential therapeutic applications of recombinant, invasive E. coli","volume":"11","author":"Critchley","year":"2004","journal-title":"Gene Therapy"},{"issue":"1","key":"10.1016\/j.ejpb.2018.04.023_b0190","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1073\/pnas.1112828109","article-title":"The rational design of a synthetic polymer nanoparticle that neutralizes a toxic peptide in vivo","volume":"109","author":"Hoshino","year":"2012","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ejpb.2018.04.023_b0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2017.03.392","article-title":"Protein-lipid nanohybrids as emerging platforms for drug and gene delivery: challenges and outcomes","author":"Gaber","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2018.04.023_b0200","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jconrel.2016.10.023","article-title":"Hybrid protein-inorganic nanoparticles: from tumor-targeted drug delivery to cancer imaging","volume":"243","author":"Elzoghby","year":"2016","journal-title":"J. Control. Release"},{"issue":"28","key":"10.1016\/j.ejpb.2018.04.023_b0205","doi-asserted-by":"crossref","first-page":"10390","DOI":"10.1039\/c1jm10261c","article-title":"Multifunctional star polymer with reactive and thermosensitive arms and fluorescently labeled core: synthesis and its protein conjugate","volume":"21","author":"Yang","year":"2011","journal-title":"J. Mater. Chem."},{"issue":"1","key":"10.1016\/j.ejpb.2018.04.023_b0210","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1177\/0883911509354230","article-title":"PEGylation of Melittin: structural characterization and hemostatic effects","volume":"25","author":"Peng","year":"2010","journal-title":"J. Bioactive Compat. Polym."},{"key":"10.1016\/j.ejpb.2018.04.023_b0215","first-page":"1","article-title":"Multi-reservoir phospholipid shell encapsulating protamine nanocapsules for co-delivery of letrozole and celecoxib in breast cancer therapy","author":"Elzoghby","year":"2017","journal-title":"Pharm. Res."},{"issue":"4","key":"10.1016\/j.ejpb.2018.04.023_b0220","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/0022-2836(89)90602-5","article-title":"Structure of human lactoferrin: crystallographic structure analysis and refinement at 2\u00b78 \u00c5 resolution","volume":"209","author":"Anderson","year":"1989","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ejpb.2018.04.023_b0225","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0040-6031(94)01891-J","article-title":"Thermal analysis of spray dried products","volume":"248","author":"Corrigan","year":"1995","journal-title":"Thermochimica Acta"},{"issue":"1","key":"10.1016\/j.ejpb.2018.04.023_b0230","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ijpharm.2010.04.041","article-title":"Hydrotropic hyaluronic acid conjugates: synthesis, characterization, and implications as a carrier of paclitaxel","volume":"394","author":"Saravanakumar","year":"2010","journal-title":"Int. J. Pharm."},{"issue":"3","key":"10.1016\/j.ejpb.2018.04.023_b0235","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0031-9422(77)80054-X","article-title":"Amino acid composition of zein molecular components","volume":"16","author":"Gianazza","year":"1977","journal-title":"Phytochemistry"},{"issue":"1","key":"10.1016\/j.ejpb.2018.04.023_b0240","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3168\/jds.S0022-0302(91)78144-7","article-title":"Heat stability of bovine lactoferrin at acidic pH","volume":"74","author":"Abe","year":"1991","journal-title":"J. Dairy Sci."},{"issue":"1","key":"10.1016\/j.ejpb.2018.04.023_b0245","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/jps.10533","article-title":"Polymer\u2013drug compatibility: a guide to the development of delivery systems for the anticancer agent, ellipticine","volume":"93","author":"Liu","year":"2004","journal-title":"J. Pharm. Sci."},{"issue":"10","key":"10.1016\/j.ejpb.2018.04.023_b0250","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1002\/pola.20669","article-title":"Characterization of ring-opening polymerization of genipin and pH-dependent cross-linking reactions between chitosan and genipin","volume":"43","author":"Mi","year":"2005","journal-title":"J. Polym. Sci., Part A: Polym. Chem."},{"key":"10.1016\/j.ejpb.2018.04.023_b0255","doi-asserted-by":"crossref","unstructured":"J.-i. Kawahara, et al., Chemical cross-linking by glutaraldehyde between amino groups: its mechanism and effects, in: Polymer Modification, Springer, 1997, pp. 119\u2013131.","DOI":"10.1007\/978-1-4899-1477-4_11"},{"issue":"1","key":"10.1016\/j.ejpb.2018.04.023_b0260","first-page":"1","article-title":"Utilization of crosslinked starch nanoparticles as a carrier for indomethacin and acyclovir drugs","volume":"6","author":"El-Feky","year":"2015","journal-title":"J. Nanomed. Nanotechnol."},{"issue":"2","key":"10.1016\/j.ejpb.2018.04.023_b0265","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3109\/10717544.2013.766781","article-title":"Studies on lactoferrin nanoparticles of gambogic acid for oral delivery","volume":"20","author":"Zhang","year":"2013","journal-title":"Drug Del."},{"issue":"11","key":"10.1016\/j.ejpb.2018.04.023_b0270","doi-asserted-by":"crossref","first-page":"9565","DOI":"10.1039\/C6NJ02539K","article-title":"Design and synthesis of new s-triazine polymers and their application as nanoparticulate drug delivery systems","volume":"40","author":"Khattab","year":"2016","journal-title":"New J. Chem."},{"key":"10.1016\/j.ejpb.2018.04.023_b0275","doi-asserted-by":"crossref","unstructured":"N. O'riordan et al., Structural and functional characteristics of bovine milk protein glycosylation, Glycobiology 24(3) (2014) 220\u2013236.","DOI":"10.1093\/glycob\/cwt162"},{"issue":"7","key":"10.1016\/j.ejpb.2018.04.023_b0280","doi-asserted-by":"crossref","first-page":"754","DOI":"10.3109\/03639045.2010.539232","article-title":"Lyophilization monophase solution technique for preparation of amorphous flutamide dispersions","volume":"37","author":"Elgindy","year":"2011","journal-title":"Drug Dev. Ind. Pharmacy"},{"issue":"1","key":"10.1016\/j.ejpb.2018.04.023_b0285","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1208\/s12249-010-9382-3","article-title":"Freeze thaw: a simple approach for prediction of optimal cryoprotectant for freeze drying","volume":"11","author":"Date","year":"2010","journal-title":"AAPS PharmSciTech"},{"issue":"4","key":"10.1016\/j.ejpb.2018.04.023_b0290","doi-asserted-by":"crossref","first-page":"446","DOI":"10.3109\/03639045.2010.522190","article-title":"Lyophilized flutamide dispersions with polyols and amino acids: preparation and in vitro evaluation","volume":"37","author":"Elgindy","year":"2011","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"3","key":"10.1016\/j.ejpb.2018.04.023_b0295","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.nano.2008.03.007","article-title":"Development, characterization, and toxicity evaluation of amphotericin B\u2013loaded gelatin nanoparticles","volume":"4","author":"Nahar","year":"2008","journal-title":"Nanomed.: Nanotechnol., Biol. Med."},{"issue":"2","key":"10.1016\/j.ejpb.2018.04.023_b0300","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.colsurfb.2011.02.018","article-title":"Development of lauroyl sulfated chitosan for enhancing hemocompatibility of chitosan","volume":"84","author":"Shelma","year":"2011","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"1","key":"10.1016\/j.ejpb.2018.04.023_b0305","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/0006-291X(91)90952-4","article-title":"Lactoferrin activates plasma membrane oxidase and Na+ H+ antiport activity","volume":"176","author":"Sun","year":"1991","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3\u20134","key":"10.1016\/j.ejpb.2018.04.023_b0310","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1515\/znc-2003-3-420","article-title":"Lactoferrin-protector against oxidative stress and regulator of glycolysis in human erythrocytes","volume":"58","author":"Maneva","year":"2003","journal-title":"Zeitschrift f\u00fcr Naturforschung C"},{"issue":"6","key":"10.1016\/j.ejpb.2018.04.023_b0315","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1016\/j.jprot.2012.01.003","article-title":"Do plasma proteins distinguish between liposomes of varying charge density?","volume":"75","author":"Capriotti","year":"2012","journal-title":"J. Proteomics"},{"issue":"1","key":"10.1016\/j.ejpb.2018.04.023_b0320","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/ddr.20063","article-title":"Amphiphilic block copolymer micelles for nanoscale drug delivery","volume":"67","author":"Kwon","year":"2006","journal-title":"Drug Dev. Res."},{"issue":"4","key":"10.1016\/j.ejpb.2018.04.023_b0325","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S1535-6108(03)00248-4","article-title":"Targeting the PI3K-Akt pathway in human cancer: rationale and promise","volume":"4","author":"Luo","year":"2003","journal-title":"Cancer Cell"},{"issue":"8","key":"10.1016\/j.ejpb.2018.04.023_b0330","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1161\/ATVBAHA.109.185918","article-title":"Rapamycin inhibition of the Akt\/mTOR pathway blocks select stages of VEGF-A164\u2013Driven Angiogenesis, in Part by Blocking S6Kinase","volume":"29","author":"Xue","year":"2009","journal-title":"Arteriosclerosis, Thromb., Vasc. Biol."},{"issue":"3","key":"10.1016\/j.ejpb.2018.04.023_b0335","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.vph.2014.01.010","article-title":"Wogonin inhibits H 2 O 2-induced angiogenesis via suppressing PI3K\/Akt\/NF-\u03baB signaling pathway","volume":"60","author":"Zhou","year":"2014","journal-title":"Vasc. Pharmacol."},{"issue":"8","key":"10.1016\/j.ejpb.2018.04.023_b0340","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.ctrv.2013.03.009","article-title":"Targeting the PI3K\/AKT\/mTOR and Raf\/MEK\/ERK pathways in the treatment of breast cancer","volume":"39","author":"Saini","year":"2013","journal-title":"Cancer Treat. Rev."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641117313681?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641117313681?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,28]],"date-time":"2019-06-28T06:46:55Z","timestamp":1561704415000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641117313681"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":68,"alternative-id":["S0939641117313681"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2018.04.023","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Self-assembled amphiphilic zein-lactoferrin micelles for tumor targeted co-delivery of rapamycin and wogonin to breast cancer","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2018.04.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}